Elevance Health Plunges 5.21% on Lowered Earnings Outlook

On May 13, 2025, Elevance Health's stock experienced a significant drop of 5.21% in pre-market trading, indicating a notable shift in investor sentiment.

Analysts have revised their expectations for Elevance Health's second-quarter earnings, with Zacks Research analyst K. Dey now projecting earnings per share of $9.36, down from the previous estimate of $9.85. This adjustment reflects a more cautious outlook on the company's financial performance.

Elevance Health's current Zacks Rank of 3 suggests that the stock is expected to perform in line with the broader market, rather than outperform. This rating indicates a neutral stance on the company's prospects, which may contribute to the recent decline in stock price.